HF
AYTU icon

HRT Financial’s AYTU BioPharma AYTU Stock Holding History

HRT Financial’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,988
Closed -$43K – 2850
2025
Q2 		$43K Buy
+19,988
New +$31K ﹤0.01% 2324
2023
Q1 		– Sell
-780
Closed -$2K – 2487
2022
Q4 		$2K Buy
+780
New +$2.94K ﹤0.01% 2326
2021
Q4 		– Sell
-1,364
Closed -$78K – 3175
2021
Q3 		$78K Sell
1,364
-1,468
-52% -$110K ﹤0.01% 2962
2021
Q2 		$283K Buy
+2,832
New +$332K ﹤0.01% 2172

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

HRT Financial's AYTU Position: Q3 2025 in Review

HRT Financial sold out of AYTU BioPharma (AYTU) in Q3 2025, closing a stake of 19,988 shares — an estimated $43K sold.

HRT Financial first reported a position in AYTU in Q2 2021 and held it in 4 quarters. The position peaked at $283K in Q2 2021. 33 funds tracked by Wall St. Rank hold AYTU as of Q3 2025.

  • HRT Financial reported no remaining AYTU BioPharma position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 19,988 AYTU BioPharma shares in Q3 2025, an estimated $43K.
  • HRT Financial first reported a position in AYTU BioPharma in Q2 2021 and held it in 4 quarters.
  • HRT Financial's AYTU BioPharma position peaked at $283K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.